Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CXC-chemokine antagonists isolated from Rhipicephalus sanguineus

CXC-chemokine antagonists isolated from Rhipicephalus sanguineus

US Patent 7670802 · Granted Mar 2, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatmen2023
Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatmen2020
Antibodies specific for MMP92019
Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment2018
Monoclonal antibody directed against CXCR52017
Treatment of fibrotic disease2012
vWFA and/or ANT—IG domain containing proteins2012
Cell surface glycoprotein2012
Method of treatment comprising administration of a cytokine antagonist molecule2010
Soluble CD164 polypeptides2010
Soluble CD164 polypeptides2010
Therapeutic uses of chemokine variants2010